EALIXIR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.6 USD | -11.60% |
|
-10.61% | -20.20% |
| Apr. 03 | Ealixir, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 30 | Ealixir, Inc. Announces Board Changes | CI |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 138.2 | 342 | 287.6 | 120.9 |
| Enterprise Value (EV) 1 | 138.2 | 342.5 | 288.3 | 121.2 |
| P/E ratio | -219 x | 2,511 x | 1,185 x | -98.8 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 74.6 x | 96.8 x | 69.5 x | 23.9 x |
| EV / Revenue | 74.7 x | 96.9 x | 69.6 x | 24 x |
| EV / EBITDA | -324 x | -885 x | 1,049 x | -125 x |
| EV / FCF | - | -305,880,263 x | -1,245,165,272 x | 96,292,192 x |
| FCF Yield | - | -0% | -0% | 0% |
| Price to Book | -82 x | -294 x | -456 x | -359 x |
| Nbr of stocks (in thousands) | 36,080 | 45,599 | 48,260 | 60,282 |
| Reference price 2 | 3.830 | 7.500 | 5.960 | 2.005 |
| Announcement Date | 2/10/23 | 2/10/23 | 8/14/23 | 4/3/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net sales 1 | 1.852 | 3.535 | 4.14 | 5.052 |
| EBITDA 1 | -0.4267 | -0.3868 | 0.2748 | -0.9663 |
| EBIT 1 | -0.4306 | -0.4287 | 0.2741 | -0.9762 |
| Operating Margin | -23.26% | -12.13% | 6.62% | -19.32% |
| Earnings before Tax (EBT) 1 | -0.4542 | 0.1716 | 0.2669 | -1.366 |
| Net income 1 | -0.6309 | 0.1218 | 0.2428 | -1.189 |
| Net margin | -34.08% | 3.45% | 5.87% | -23.53% |
| EPS 2 | -0.0175 | 0.002987 | 0.005031 | -0.0203 |
| Free Cash Flow | - | -1.12 | -0.2315 | 1.259 |
| FCF margin | - | -31.67% | -5.59% | 24.92% |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 2/10/23 | 2/10/23 | 8/14/23 | 4/3/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Net Debt 1 | 0.06 | 0.47 | 0.66 | 0.37 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.1437 x | -1.224 x | 2.411 x | -0.3844 x |
| Free Cash Flow | - | -1.12 | -0.23 | 1.26 |
| ROE (net income / shareholders' equity) | - | -8.72% | -27.2% | 247% |
| ROA (Net income/ Total Assets) | - | -23.3% | 8.84% | -27.4% |
| Assets 1 | - | -0.5232 | 2.745 | 4.331 |
| Book Value Per Share 2 | -0.0500 | -0.0300 | -0.0100 | -0.0100 |
| Cash Flow per Share 2 | 0 | 0.0100 | 0 | 0 |
| Capex | - | 0.37 | - | - |
| Capex / Sales | - | 10.48% | - | - |
| Announcement Date | 2/10/23 | 2/10/23 | 8/14/23 | 4/3/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -20.20% | 96.45M | |
| -12.23% | 194B | |
| +0.74% | 166B | |
| +2.19% | 153B | |
| +4.34% | 99.85B | |
| +7.04% | 77.56B | |
| +19.09% | 73.55B | |
| -7.30% | 71B | |
| -20.54% | 52.81B | |
| +0.53% | 47.86B |
- Stock Market
- Equities
- EAXR Stock
- Financials Ealixir, Inc.
